CAAS
SPPI

Capital Asset Advisory Services’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Capital Asset Advisory Services’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-405
Closed -$1K – 1591
2020
Q4 		$1K Buy
+405
New +$1.67K ﹤0.01% 1578

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Capital Asset Advisory Services's SPPI Position: Q1 2021 in Review

Capital Asset Advisory Services sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2021, closing a stake of 405 shares — an estimated $1K sold.

Capital Asset Advisory Services first reported a position in SPPI in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 147 funds tracked by Wall St. Rank hold SPPI as of Q1 2021.

  • Capital Asset Advisory Services reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
  • Capital Asset Advisory Services sold 405 Spectrum Pharmaceuticals Inc shares in Q1 2021, an estimated $1K.
  • Capital Asset Advisory Services first reported a position in Spectrum Pharmaceuticals Inc in Q4 2020 and held it in 1 quarter.
  • Capital Asset Advisory Services's Spectrum Pharmaceuticals Inc position peaked at $1K in Q4 2020.
  • 147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2021.

Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.